Orzeyful (oveporexton) for narcolepsy
Fact-checked by 
What is Orzeyful for narcolepsy?
Orzeyful (oveporexton) is an approved oral therapy used to treat adults with type 1 narcolepsy.
Narcolepsy is a neurological condition in which the brain can’t regulate sleep-wake cycles, leading to excessive daytime sleepiness, episodes of sudden muscle weakness (cataplexy), and other symptoms related to the intrusion of sleep into waking hours.
For people with type 1 narcolepsy, the disease is driven by a loss of nerve cells that produce orexin, a brain signaling chemical that stabilizes sleep-wake cycles and promotes alertness.
Orzeyful is designed to mimic orexin’s effects in the body, replacing the wake-promoting actions of the missing chemical. It does this by binding to and activating the receptor proteins through which orexin normally exerts its effects.
The therapy, marketed by Takeda Pharmaceuticals, is the first approved treatment that directly targets orexin loss in narcolepsy to address the full range of disease symptoms.
Therapy snapshot
| Brand name | Orzeyful |
| Chemical name | Oveporexton |
| Usage | Used to treat adults with narcolepsy type 1 |
| Administration | Oral tablets |
Who can take Orzeyful?
Orzeyful is approved in the U.S. for the treatment of adults with narcolepsy type 1.
It is contraindicated, or should not be used, in people who are taking medications that strongly inhibit the CYP3A enzyme. This enzyme breaks down Orzeyful, so CYP3A inhibitors can lead to unsafe levels of the medication in the bloodstream.
Orzeyful is also typically not recommended for people with severe liver or kidney problems, or for use alongside strong or moderate CYP3A inducers, which can reduce exposure to Orzeyful and make it less effective.
How is Orzeyful administered?
Orzeyful is taken as oral tablets, to be administered at approximately the same time each day. The recommended dose is either:
- 1 mg after waking up, then 1 mg three to five hours later
- 2 mg after waking up, then 2 mg three to five hours later
The maximum recommended total daily dose is 4 mg, though dose reductions are recommended for people taking medications that moderately inhibit CYP3A.
Tablets can be taken with or without food, and should be swallowed whole — never split, crushed, or chewed.
Orzeyful in clinical trials
U.S. regulators approved Orzeyful based on data from two global Phase 3 clinical trials — FirstLight (NCT06470828) and RadiantLight (NCT06505031) — that collectively involved 273 people with narcolepsy type 1.
In both trials, participants received either oveporexton or a placebo twice daily for about three months. Across the two studies, the data showed that, compared with the placebo, either approved dose of Orzeyful was associated with:
- an improved ability to stay awake during the day, as measured by both objective and subjective measures
- reductions in the overall severity of narcolepsy symptoms
- meaningful reductions in the rate of weekly cataplexy events
- improvements in patients’ self-reported overall clinical status
Other analyses have shown that the oral therapy was associated with improvements in daily functioning, cognition, and nighttime sleep.
Orzeyful side effects
The most common side effects associated with Orzeyful are:
- insomnia (trouble sleeping)
- frequent urination and sudden, strong urges to urinate
- excessive salivation
If insomnia persists beyond a week and significantly impacts daily functioning or quality of life, a doctor may recommend reducing the dose or discontinuing Orzeyful.
Patients will be screened for existing urinary tract problems before starting treatment. People with a history of overactive bladder may be especially prone to worsening urinary symptoms, so they need to be carefully monitored.
Orzeyful may increase blood levels of creatine phosphokinase, which can be a marker of muscle stress or damage. Patients should report any unexplained muscle pain, weakness, or dark urine to their healthcare team.
Narcolepsy News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
